Table S1. 20 hub genes with siRNA synthesizers and sequence [34â52]. (DOCX 19 kb
Table S5. Detailed information of GO analysis for the selected 20 genes. (DOCX 13Â kb
Table S1: Primer sequence. Table S2: The sequences of small interfering RNA of GTSE1. Table S3: GTSE...
Clinical characteristics of 492 gastric cancer patients involved in the study. (DOCX 15Â kb
Table S2. The adj. p value and log fold change (logFC) of the hub genes in TCGA and GSE77346 dataset...
Figure S2. The mRNA expression of hub genes in clinical stages in TCGA. (PDF 2878 kb
Table S3. Targeted drugs with corresponding GEO datasets for gastric cancer. (DOCX 18 kb
Figure S3. The mRNA expression and the fold change of the hub genes. (A) the mRNA expression of hub ...
Table S1. Detailed information of cohort 1 and 2 is listed. Table S2. Primers and RNA sequences used...
Table S1. Gene listed in KEGG cell cycle pathway (hsa04110). Table S2. Comparison of Survival Curves...
Table S3. Predicted breast cancer driver genes by the seven permutation models. Table S4. Predicted ...
Table S1. Primers for shRNA lentiviral constructs; Table S2. siRNA target sequences; Table S3. The s...
List of the 52 genes identified among the 687 tested genes in HT screening as important for the cell...
Affymetrix DNA microarray analysis of gene expression in HuH6shCTNNB1 cells in response to Dox treat...
List of genes from the five different RT² Profiler™ PCR Array Human Systems used in this study, clas...
Sequences and positions in the human genome of primers employed for amplification of regions of inte...
Table S5. Detailed information of GO analysis for the selected 20 genes. (DOCX 13Â kb
Table S1: Primer sequence. Table S2: The sequences of small interfering RNA of GTSE1. Table S3: GTSE...
Clinical characteristics of 492 gastric cancer patients involved in the study. (DOCX 15Â kb
Table S2. The adj. p value and log fold change (logFC) of the hub genes in TCGA and GSE77346 dataset...
Figure S2. The mRNA expression of hub genes in clinical stages in TCGA. (PDF 2878 kb
Table S3. Targeted drugs with corresponding GEO datasets for gastric cancer. (DOCX 18 kb
Figure S3. The mRNA expression and the fold change of the hub genes. (A) the mRNA expression of hub ...
Table S1. Detailed information of cohort 1 and 2 is listed. Table S2. Primers and RNA sequences used...
Table S1. Gene listed in KEGG cell cycle pathway (hsa04110). Table S2. Comparison of Survival Curves...
Table S3. Predicted breast cancer driver genes by the seven permutation models. Table S4. Predicted ...
Table S1. Primers for shRNA lentiviral constructs; Table S2. siRNA target sequences; Table S3. The s...
List of the 52 genes identified among the 687 tested genes in HT screening as important for the cell...
Affymetrix DNA microarray analysis of gene expression in HuH6shCTNNB1 cells in response to Dox treat...
List of genes from the five different RT² Profiler™ PCR Array Human Systems used in this study, clas...
Sequences and positions in the human genome of primers employed for amplification of regions of inte...
Table S5. Detailed information of GO analysis for the selected 20 genes. (DOCX 13Â kb
Table S1: Primer sequence. Table S2: The sequences of small interfering RNA of GTSE1. Table S3: GTSE...
Clinical characteristics of 492 gastric cancer patients involved in the study. (DOCX 15Â kb